Publications 2003

  1. Bojarski, A. J.; Kowalski, P.; Suder, P.; Kowalska, T.; Sikorska-Jarosz, J.; Silberring, J.; Duszynska, B.; Nowak, M. ESI-mass spectrometric studies of the non-covalent complexes of triethylamine salts. Annals of the Polish Chemical Society 2003, 2, 13-17.
  2. Bugno, R.; Charakchieva-Minol, S.; Paluchowska, M. H. Arylpiperazine 2-pyrrolidinone derivatives as 5-HT1A receptor ligands. Annals of the Polish Chemical Society 2003, 2, 260-264.
  3. Boksa, J.; Charakchieva-Minol, S.; Duszynska, B.; Bugno, R.; Klodzinska, A.; Tatarczynska, E.; Chojnacka-Wojcik, E.; Bojarski, A. J. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-γ-carbolines with 1-(2-methoxyphenyl)piperazine moiety. Pol. J. Pharmacol. 2003, 55, 1013-1019 (http://www.ncbi.nlm.nih.gov/pubmed/14730096).
  4. Bojarski, A. J.; Nowak, M.; Testa, B. Conformational constraints on side chains in protein residues increase their information content. Cell. Mol. Life Sci. 2003, 60, 2526-2531 (http://www.ncbi.nlm.nih.gov/pubmed/14625695).
  5. Obniska, J.; Pawłowski, M.; Kołaczkowski, M.; Czopek, A.; Duszyńska, B.; Kłodzińska, A.; Tatarczyńska, E.; Chojnacka-Wójcik, E. Synthesis and 5-HT1A /5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-β-tetralonepyrrolidine-2,5-dione. Pol. J. Pharmacol. 2003, 55, 553-557 (http://www.ncbi.nlm.nih.gov/pubmed/14581713).
  6. Paluchowska, M. H.; Mokrosz, M. J. ; Duszyńska, B.; Kozioł, A.; Wesołowska, A.; Chojnacka-Wójcik, E. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity. Pol. J. Pharmacol. 2003, 55, 543-552 (http://www.ncbi.nlm.nih.gov/pubmed/14581712).
  7. Luchter-Wasylewska, E.; Wasylewski, M.; Röhm, K.-H. Concentration-Dependent Dissociation/Association of Human Prostatic Acid Phosphatase. J. Prot. Chem. 2003, 22, 243-247 (http://www.ncbi.nlm.nih.gov/pubmed/12962324).
  8. Karolak-Wojciechowska, J.; Fruzinski, A.; Czylkowski, R.; Paluchowska, M. H.; Mokrosz, M. J. Spacer conformation in biologically active molecules. Part 2. Structure and conformation of 4-[2-(diphenylmethylamino)ethyl]-1-(2-methoxyphenyl) piperazine and its diphenylmethoxyanalog – potential 5-HT1A receptor ligands. J. Mol. Struc. 2003, 657, 7-17.
  9. Kowalski, P.; Suder, P.; Kowalska, T.; Silberring, J.; Duszyńska, B.; Bojarski, A. J. Electrospray mass spectrometric studies of noncovalent complexes of buspirone hydrochloride and other serotonin 5-HT1A receptor ligands containing arylpiperazine moieties. Rapid Commun. Mass Spectrom. 2003, 17, 2139-2146 (http://www.ncbi.nlm.nih.gov/pubmed/12955745).
  10. Wesołowska, A.; Paluchowska, M. H.; Gołembiowska, K.; Chojnacka-Wójcik, E. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats. J. Pharm. Pharmacol. 2003, 55, 533-543 (http://www.ncbi.nlm.nih.gov/pubmed/12803776).
  11. Wesolowska, A.; Paluchowska, M.; Chojnacka-Wojcik, E. Involvement of presynaptic 5-HT(1A) and benzodiazepine receptors in the anticonflict activity of 5-HT(1A) receptor antagonists. Eur. J. Pharmacol. 2003, 471, 27-34 (http://www.ncbi.nlm.nih.gov/pubmed/12809949).
  12. Zajdel, P.; Bojarski, A. J.; Byrtus, H.; Chłoń-Rzepa, G.; Obniska, J.; Chevallet, P.; Martinez, J.; Pawłowski, M. Preliminary study on application of impregnated synthetic peptide TLC stationary phases for the prescreening of 5-HT1A ligands. Biomed. Chromatogr. 2003, 17, 312-317 (http://onlinelibrary.wiley.com/doi/10.1002/bmc.224/abstract).
  13. Paluchowska, M. H.; Bojarski, A. J.; Bugno, R.; Charakchieva-Minol, S.; Wesołowska, A. Modification of the Structure of 4, 6-Disubstituted 2-(4-Alkyl-1-piperazinyl)pyridines: Synthesis and Their 5-HT2A Receptor Activity. Arch. Pharm. (Weinheim) 2003, 336, 104-110 (http://www.ncbi.nlm.nih.gov/pubmed/12761763).
  14. Strekowski, L.; Say, M.; Henary, M.; Ruiz, P.; Manzel, L.; Macfarlane, D. E.; Bojarski, A. J. Synthesis and activity of substituted 2-phenylquinolin-4-amines, antagonists of immunostimulatory CpGoligodeoxynucleotides. J. Med. Chem. 2003, 46, 1242-1249 (http://www.ncbi.nlm.nih.gov/pubmed/12646034).
  15. Antkiewicz-Michaluk, L.; Karolewicz, B.; Romańska, I.; Michaluk, J.; Bojarski, A. J.; Vetulani, J. 1-Methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain. Eur. J. Pharmacol. 2003, 466, 263-269 (http://www.ncbi.nlm.nih.gov/pubmed/12694809)